Clearstead Advisors, LLC Biote Corp. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Biote Corp. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 86 shares of BTMD stock, worth $256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86Holding current value
$256% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BTMD
# of Institutions
97Shares Held
16.3MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$13.6 Million8.28% of portfolio
-
Bandera Partners LLC New York, NY2.28MShares$6.81 Million4.11% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$4.24 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA685KShares$2.04 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $22.6M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...